Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone right now:

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.

Image source: Getty Images

Capricorn Metals Ltd (ASX: CMM)

According to a note out of Bell Potter, its analysts have retained their buy rating on this gold miner's shares with an improved price target of $6.49. Bell Potter has been looking over Capricorn Metals' FY 2024 results and was pleased with what it saw. It highlights that the company still achieved very strong EBITDA margins despite facing weather disruptions and lower production year on year. Outside this, the broker believes that Capricorn Metals would be a great option for investors looking for exposure to gold. This is because it is a sector leading gold producer with a strong balance sheet, has a management team with an excellent track record of delivery, and a clear organic growth options to lift group production to 270,000 ounces per annum. The Capricorn Metals share price is trading at $5.52 today.

Challenger Ltd (ASX: CGF)

A note out of Goldman Sachs reveals that its analysts have retained their buy rating and $8.00 price target on this annuities company's shares. This follows news that strategic partner and major shareholder, Apollo, has been selling down its stake in the company. While Goldman believes there is now a greater risk of a potential further sell down, particularly if the risk/reward dynamic does not stack up relative to new opportunities, it was comforted by confirmation that both Apollo and Challenger remain committed to their ongoing commercial partnership. This is focused on asset origination and establishing a non-bank lending joint venture in Australia. Outside this, the broker is positive on the company due to its exposure to the growing superannuation market across Life and Funds Management. It also expects higher yields to drive a favourable sales environment for retail annuities and support margin improvements. The Challenger share price is fetching $6.29 on Friday.

REA Group Ltd (ASX: REA)

Analysts at Macquarie have retained their outperform rating on this property listings company's shares with an improved price target of $229.00. This follows news that REA Group is looking at a possible takeover of UK peer Rightmove (LSE: RMV). Macquarie estimates that the company would need to raise $6.1 billion of equity to acquire the company. But this could still be worth it given its expectation that a 20% takeover premium could result in earnings per share accretion of 14%. The REA Group share price is trading at $205.85 at the time of writing.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Macquarie Group, and REA Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Rightmove Plc. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Challenger and REA Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Down 43% this week, are Cochlear shares now the best bargain buy of the year?

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

Wesfarmers shares: Buy, hold or sell?

A leading analyst delivers his verdict on Wesfarmers shares.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, CSL, and DroneShield shares

Are these hugely popular shares in the buy zone or not? Let's find out.

Read more »

Man with rocket wings which have flames coming out of them.
Broker Notes

These ASX 200 shares could rise ~40% to 80%

Brokers are predicting big returns for these top shares. Here's what you need to know.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Broker Notes

2 ASX 200 stocks that could rise 50%

Morgans thinks the market is undervaluing these shares.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Dollar sign in yellow with a red falling arrow in front of a graph, symbolising a falling share price.
Broker Notes

6 ASX 200 shares downgraded by brokers this week

Brokers have reduced their ratings on TechnologyOne, Macquarie, 4DMedical, and others this week.

Read more »